Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activity
Brodie L. Bailey, William Nguyen, Anna Ngo, C.D. Goodman, Maria R. Gancheva, Paola Favuzza, Laura M. Sanz, Francisco‐Javier Gamo, Kym N. Lowes, Geoffrey I. McFadden, Danny W. Wilson, Benoı̂t Laleu, Stephen Brand, Paul Jackson, Alan F. Cowman, Brad E. Sleebs
Topics & Concepts
Plasmodium falciparumMalariaCarboxamidePhenotypic screeningChemistryDrug discoveryADMEIn vitroBiologyPharmacologyGeneDrugPhenotypeBiochemistryImmunologyMalaria Research and ControlHIV/AIDS drug development and treatmentTrypanosoma species research and implications